Treatment of chronic lymphocytic leukemia with del(17p)/TP53 mutation: allogeneic hematopoietic stem cell transplantation or BCR-signaling inhibitors? - Montserrat, Emili; Dreger, Peter (Clinical lymphoma, myeloma & leukemia, 2016)
Gesehen am 08.09.2020